CN115153028A - Microbial oral liquid - Google Patents
Microbial oral liquid Download PDFInfo
- Publication number
- CN115153028A CN115153028A CN202210898904.5A CN202210898904A CN115153028A CN 115153028 A CN115153028 A CN 115153028A CN 202210898904 A CN202210898904 A CN 202210898904A CN 115153028 A CN115153028 A CN 115153028A
- Authority
- CN
- China
- Prior art keywords
- oral liquid
- parts
- black
- ginseng
- microbial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 26
- 230000000813 microbial effect Effects 0.000 title claims abstract description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 11
- 239000011707 mineral Substances 0.000 claims abstract description 11
- 235000000346 sugar Nutrition 0.000 claims abstract description 11
- 241000208340 Araliaceae Species 0.000 claims abstract description 10
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 10
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 10
- 235000008434 ginseng Nutrition 0.000 claims abstract description 10
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims abstract description 8
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 8
- 238000000855 fermentation Methods 0.000 claims abstract description 8
- 230000004151 fermentation Effects 0.000 claims abstract description 8
- 235000012907 honey Nutrition 0.000 claims abstract description 8
- 244000005700 microbiome Species 0.000 claims abstract description 8
- 238000002360 preparation method Methods 0.000 claims abstract description 7
- 240000000249 Morus alba Species 0.000 claims abstract description 6
- 240000001341 Reynoutria japonica Species 0.000 claims abstract description 6
- 235000018167 Reynoutria japonica Nutrition 0.000 claims abstract description 6
- 241000229143 Hippophae Species 0.000 claims abstract 6
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims abstract 4
- 235000017784 Mespilus germanica Nutrition 0.000 claims abstract 4
- 244000182216 Mimusops elengi Species 0.000 claims abstract 4
- 235000000560 Mimusops elengi Nutrition 0.000 claims abstract 4
- 235000007837 Vangueria infausta Nutrition 0.000 claims abstract 4
- 238000002791 soaking Methods 0.000 claims abstract 3
- 235000003935 Hippophae Nutrition 0.000 claims abstract 2
- 238000004140 cleaning Methods 0.000 claims abstract 2
- 238000001816 cooling Methods 0.000 claims abstract 2
- 239000000706 filtrate Substances 0.000 claims abstract 2
- 238000001914 filtration Methods 0.000 claims abstract 2
- 238000010438 heat treatment Methods 0.000 claims abstract 2
- 238000007789 sealing Methods 0.000 claims abstract 2
- 241000894006 Bacteria Species 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 7
- 230000008569 process Effects 0.000 claims description 4
- 244000241838 Lycium barbarum Species 0.000 claims description 2
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 2
- 235000015468 Lycium chinense Nutrition 0.000 claims description 2
- 238000009835 boiling Methods 0.000 claims 1
- 240000000950 Hippophae rhamnoides Species 0.000 abstract description 4
- 230000036541 health Effects 0.000 abstract description 2
- 239000000047 product Substances 0.000 abstract 1
- 235000001014 amino acid Nutrition 0.000 description 14
- 150000001413 amino acids Chemical class 0.000 description 14
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 12
- 239000004472 Lysine Substances 0.000 description 12
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 12
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 230000036039 immunity Effects 0.000 description 10
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 7
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 6
- 241000169546 Lycium ruthenicum Species 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 239000011575 calcium Substances 0.000 description 6
- 229910052791 calcium Inorganic materials 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 229910052742 iron Inorganic materials 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- 229930002877 anthocyanin Natural products 0.000 description 5
- 235000010208 anthocyanin Nutrition 0.000 description 5
- 239000004410 anthocyanin Substances 0.000 description 5
- 150000004636 anthocyanins Chemical class 0.000 description 5
- 235000010755 mineral Nutrition 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 239000011591 potassium Substances 0.000 description 5
- 229910052700 potassium Inorganic materials 0.000 description 5
- 235000007686 potassium Nutrition 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 229930003427 Vitamin E Natural products 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- 235000019165 vitamin E Nutrition 0.000 description 4
- 239000011709 vitamin E Substances 0.000 description 4
- 229940046009 vitamin E Drugs 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000186660 Lactobacillus Species 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 229940039696 lactobacillus Drugs 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241001289529 Fallopia multiflora Species 0.000 description 2
- 241000218231 Moraceae Species 0.000 description 2
- 208000005718 Stomach Neoplasms Diseases 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 206010017758 gastric cancer Diseases 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000006041 probiotic Substances 0.000 description 2
- 235000018291 probiotics Nutrition 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 201000011549 stomach cancer Diseases 0.000 description 2
- 206010001497 Agitation Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010015866 Extravasation Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 206010049565 Muscle fatigue Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 150000001453 anthocyanidins Chemical class 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 230000036251 extravasation Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000036046 immunoreaction Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000001596 intra-abdominal fat Anatomy 0.000 description 1
- 208000012866 low blood pressure Diseases 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 238000010827 pathological analysis Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 230000000243 photosynthetic effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 210000002363 skeletal muscle cell Anatomy 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000025366 tissue development Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
- A23L31/10—Yeasts or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention belongs to the technical field of health care products, and particularly relates to a microbial oral liquid. The microbial oral liquid is prepared from the following raw materials in parts by weight: 1-2 parts of original mushroom mother, 90-100 parts of mineral water, 0.2-0.4 part of red date, 0.1-0.3 part of black medlar, 0.05-0.15 part of mulberry, 0.1-0.3 part of sea buckthorn, 0.1-0.3 part of black fleece-flower root, 1-3 parts of brown sugar, 0.3-0.5 part of honey and 0.05-0.15 part of ginseng. The preparation method of the microbial oral liquid comprises the following steps: (1) cleaning raw materials; (2) Soaking fructus Jujubae, mori fructus, fructus Hippophae, polygoni Multiflori radix and Ginseng radix in mineral water, and decocting; (3) Stopping heating, adding brown sugar, adding fructus Lycii when the temperature reaches 45-55 deg.C, adding Mel when the temperature is reduced to 17-23 deg.C, cooling, filtering, adding original strain mother culture to the filtrate, sealing in fermentation tank, fermenting, and making into microorganism oral liquid.
Description
Technical Field
The invention belongs to the technical field of health care products, and particularly relates to a microbial oral liquid.
Background
During the cultivation process of the microbial probiotics, a large amount of gas is generated due to insufficient cultivation time of the active bacteria under the anaerobic condition, and the microbial probiotics are difficult to transport.
Disclosure of Invention
In order to solve the technical problems, the invention provides a microbial oral liquid.
In order to achieve the purpose, the invention adopts the following technical scheme:
the invention relates to a microorganism oral liquid prepared by using perennial yeast, herbal medicine and traditional Chinese medicine, which comprises the following components by 100 kg: 1.5 kg of original bacterial strain spring yeast, 95 kg of mineral water, 0.3 kg of red date, 0.2 kg of black wolfberry, 0.1 kg of mulberry, 0.2 kg of sea buckthorn, 0.2 kg of black fleece-flower root, 2 kg of brown sugar, 0.4 kg of honey and 0.1 kg of ginseng are prepared to obtain the microbial oral liquid, and the main components of the microbial oral liquid are yeast, amino acid and lysine.
Yeast: unicellular microorganisms, fungi of higher microorganisms, are very strong antioxidants, can protect the liver, and have detoxifying effects. After fermentation, phytic acid which influences the absorption of elements such as calcium, magnesium, iron and the like is decomposed, so that the absorption and utilization of the nutrients by a human body are improved.
Lactic acid bacteria: the lactobacillus can regulate normal flora of gastrointestinal tract of organism, maintain microecological balance, improve food digestibility and biovalue, reduce serum cholesterol, control endotoxin, inhibit growth and reproduction of putrefying bacteria and generation of putrefying products in intestinal tract, produce nutrient substances, and stimulate tissue development, thereby acting on nutritional state, physiological function, cell infection, drug effect, toxic reaction, immunoreaction, tumorigenesis, aging process, sudden emergency reaction, etc.
Lysine: (1) Promoting growth and development of human body, and promoting development of proliferating cells and basic substance of human body, such as myocardial cell and skeletal muscle cell.
(2) The lysine can obviously enhance essential amino acid of human body immunity, and the lack of lysine can obviously reduce the immunity and can cause influenza, viral influenza and other cold conditions.
(3) Stabilize and improve central nervous function, and can be used for treating insomnia, dreaminess, rest, sleep disorder, and hypomnesis. Lysine also has good effect and curative effect on the digestive system, and has good effect on normal digestion and absorption of food and digestion and absorption of nutrient substances.
(4) Lysine is also effective in preventing osteoporosis and helping calcium ions deposit on bone.
Amino acids: (1) promoting the immunity of the organism: the amino acid is the constitution of the body immunity substance and can provide abundant raw materials, so the amino acid is properly supplemented, the generation of the body immunity substance can be promoted, and the body immunity can be improved. For people with low resistance and easy illness, amino acid is supplemented properly, certain diseases can be avoided, and the effect of reducing the disease incidence is obvious.
(2) The muscle synthesis promotion can provide raw materials for muscle synthesis, and has positive effects on promoting the synthesis of skeletal muscle for people who often do physical labor or do physical exercise, if amino acid is properly supplemented, improving muscle strength, relieving muscle fatigue, and preventing and relieving muscle decay syndrome.
(3) Soothing nerves and helping sleep: the amino acid can also regulate the metabolism of the nervous system in vivo, so that the amino acid is properly supplemented to the people with insomnia and dreaminess, and the functions of calming the nerves and helping sleep are achieved.
The main nutrient components comprise:
nutrient composition table
Item | The result of the detection | Reference value of nutrients% |
Yeast, CFU-mL | <1 | CFU/mL |
Lactobacillus, CFU-mL | 3.5×10 7 | CFU/mL |
Lysine, g/100g | 0.00992 | g/100g |
Anthocyanidin, mg/kg | 11.9 | mg/kg |
Calcium, mg/kg | 121 | mg/kg |
Potassium, mg/100g | 38.9 | mg/100g |
Amino acid, g/100g | 0.0450 | g/100g |
Iron, mg/kg | 3.39 | mg/kg |
Protein, g/100g | 0.13 | g/100g |
Calcium, iron, anthocyanin, potassium, lysine, amino acid, protein, lactobacillus and yeast.
Calcium: can regulate cell function and influence a plurality of enzyme activities in vivo; maintaining normal excitability of nerves and muscles together with magnesium ions, potassium ions, sodium ions and the like; also participate in the clotting process as a coagulation V factor; calcium also reduces permeability of cell membranes and capillaries, prevents extravasation, and inhibits inflammation and edema.
Iron: plays a key role in the process of conveying oxygen from the lung to tissues, promotes the synthesis of collagen, the generation of antibodies, the transportation of lipid from blood, the detoxification of drugs in the liver and the like, can improve the immunity of the organism, increases the phagocytic function of neutrophils and phagocytic cells, and simultaneously can also enhance the anti-infection capability of the organism.
And (3) anthocyanin: can remove free radicals, and has good antioxidant and antiaging effects. Has strong prevention effect on cardiovascular and cerebrovascular diseases, can adjust the metabolism of fat in blood, avoids the deposition of the lipid on the inner wall of the blood vessel, and can ensure that the vessel wall is more elastic. Reducing chronic diseases such as cerebral infarction, myocardial infarction, lower limb atherosclerosis, etc.
Potassium: can maintain cardiac muscle and reduce cardiac problems such as arrhythmia; can maintain nervous system, and reduce insomnia, nerve disorder, and mental instability. Normal water content of cells can be maintained, water molecule loss of a human body is locked, and balance is achieved; the balance of the pH value of the human body can be regulated; can carry and treat the blood vessels and the garbage in the human body, reduce the harmful substances such as carbon dioxide and the like from remaining in the human body, thereby providing better oxygen supply for the brain.
Manganese: participate in the synthesis and activation of various enzymes, and promote the synthesis of cholesterol, protein, vitamin B1 and vitamin C. Improve the absorption and utilization of protein in human body, accelerate the oxidation of fat in cells, reduce the accumulation of visceral fat, protect cardiovascular and cerebrovascular vessels, and regulate blood sugar, blood fat and blood pressure. Stimulating immune cell proliferation, and enhancing immunity. Can destroy free radicals to prevent cancer.
Vitamin E: the fat-soluble vitamin is one of antioxidants, protects cell membranes so as to avoid genetic genes from being damaged by the genes, effectively improves the functions of the autoimmune system of a human body, and can enhance the capacity of the human body to remove cancer cells, thereby delaying aging. And can also regulate the sex hormone level of human body.
The main components have the following effects: resisting oxidation, resisting aging, relieving fatigue, enhancing immunity, preventing cancer, promoting sleep and digestion.
Antioxidation: yeast, anthocyanins;
anti-aging: anthocyanins, vitamin E;
and (3) fatigue resistance: amino acids, potassium;
and (3) enhancing immunity: amino acids, lysine, iron, manganese, vitamin E;
prevention of cancer: lactic acid bacteria, manganese, vitamin E;
sleeping and aiding digestion: yeast, amino acids, lysine.
The specific preparation method of the microbial oral liquid comprises the following steps: firstly, 0.3 kg of red dates, 0.2 kg of lycium ruthenicum, 0.1 kg of mulberries, 0.2 kg of sea-buckthorn, 0.2 kg of polygonum multiflorum and 0.1 kg of ginseng are washed clean with clear water, the floating soil on the materials is washed down, 95 kg of mineral water is added into the raw materials after the raw materials are washed clean, the lycium ruthenicum is removed and is soaked for 40 minutes in 95 kg of mineral water, the raw materials are placed in a stainless steel pot and decocted to be boiled with big fire, then the mixture is decocted for 30 minutes with small fire, 2 kg of brown sugar is added after the fire is turned off, the temperature reaches 50 ℃, 0.2 kg of lycium ruthenicum is added, 0.4 kg of honey is added when the temperature is reduced to about 20 ℃ after 30 minutes, the mixture is cooled, juice is extracted, 1.5 kg of original yeast is placed in a fermentation tank, the fermentation tank is placed for 15 days in a closed manner, and the whole production process is disinfected at high temperature and produced aseptically.
Compared with the prior art, the invention has the following beneficial effects; the prepared microbial oral liquid is a self-cultured original yeast, has stronger stability and more obvious curative effect, and contains the combination of self-carried yeast, lactic acid bacteria, photosynthetic bacteria, bifidobacterium, acetic acid bacteria, bacillus and six strains, and also contains various trace elements such as anthocyanin, strontium, calcium, potassium, lysine, amino acid, iron, protein and the like. After the microorganism oral liquid is used, people with good appetite, good sleep, abundant energy, no common cold, and low blood pressure tend to be normal, wherein the microorganism oral liquid is rich in lysine, and can increase serum albumin. Has the inhibiting effect on various tumor cells, obviously relieves the illness state of the sick people, quickly recovers the illness state of the sick people, and has more obvious effect when the sick people are seriously ill.
The oral administration method comprises the following steps: about 25 ml for 1 time and 2 times in 1 day. After meals, the tea can be put into warm boiled water at about 40 ℃ and added with brown sugar or honey to achieve better drinking effect.
Drawings
Fig. 1-2 are admission records for patients in example 1.
Fig. 3 is an electronic gastroscopic report of the patient of example 1.
Fig. 4 is a report of pathological diagnosis of the patient in example 1.
FIG. 5 is a color computer ultrasound image report of the patient of example 1.
Figure 6 is a record of discharge from the patient of example 1.
Fig. 7-9 are discharge records of patients in example 2.
Fig. 10-11 are test reports for the patient of example 2.
Detailed Description
Test example 1
A specific preparation method of the microorganism oral liquid comprises the following steps: firstly, 0.3 kg of red dates, 0.2 kg of lycium ruthenicum, 0.1 kg of mulberries, 0.2 kg of sea-buckthorn, 0.2 kg of polygonum multiflorum and 0.1 kg of ginseng are washed clean with clear water, the floating soil on the materials is washed down, 95 kg of mineral water is added into the raw materials after the raw materials are washed clean, the lycium ruthenicum is removed and is soaked for 40 minutes in 95 kg of mineral water, the raw materials are placed in a stainless steel pot and decocted to be boiled with big fire, then the mixture is decocted for 30 minutes with small fire, 2 kg of brown sugar is added after the fire is turned off, the temperature reaches 50 ℃, 0.2 kg of lycium ruthenicum is added, 0.4 kg of honey is added when the temperature is reduced to about 20 ℃ after 30 minutes, the mixture is cooled, juice is extracted, 1.5 kg of original yeast is placed in a fermentation tank, the fermentation tank is placed for 15 days in a closed manner, and the whole production process is disinfected at high temperature and produced aseptically.
Example 1
Yuzhi, male, 78 years old, 2015, 6 months and 29 days, gastric cancer is diagnosed without operation, and the effect of taking the microbial oral liquid prepared in test example 1 is obvious, so far, the oral liquid is in the best condition and is healthy. The admission record of the patient is shown in fig. 1-2, the electronic gastroscope report is shown in fig. 3, the case diagnosis report is shown in fig. 4, the color computer ultrasonic image report is shown in fig. 5, and the discharge record is shown in fig. 6.
Example 2
In Zhongzhi, a woman in age of 54 and in 2019 in 21 months of 11, the late gastric cancer is diagnosed, the effect is obvious after the doctor takes the microbial oral liquid prepared in the test example 1, and the Zhongzhi oral liquid is in the present and healthy state. The patient's discharge record is shown in figures 7-9 and the test report is shown in figures 10-11.
The above-described embodiments are merely illustrative of the preferred embodiments of the present invention, and do not limit the scope of the present invention, and various modifications and improvements of the technical solutions of the present invention can be made by those skilled in the art without departing from the spirit of the present invention, and the technical solutions of the present invention are within the scope of the present invention defined by the claims.
Claims (8)
1. The microbial oral liquid is characterized by being prepared from the following raw materials: original mushroom mother, mineral water, red dates, black wolfberry, mulberry, sea buckthorn, black fleece-flower root, brown sugar, honey and ginseng.
2. The microbial oral liquid of claim 1, wherein the raw materials are added in the following weight proportions: 1-2 parts of original mushroom mother, 90-100 parts of mineral water, 0.2-0.4 part of red date, 0.1-0.3 part of black medlar, 0.05-0.15 part of mulberry, 0.1-0.3 part of sea buckthorn, 0.1-0.3 part of black fleece-flower root, 1-3 parts of brown sugar, 0.3-0.5 part of honey and 0.05-0.15 part of ginseng.
3. The microbial oral liquid of claim 2, wherein the raw materials are added in the following weight proportions: 1.5 parts of original mushroom mother, 95 parts of mineral water, 0.3 part of red date, 0.2 part of black medlar, 0.1 part of mulberry, 0.2 part of sea buckthorn, 0.2 part of black fleece-flower root, 2 parts of brown sugar, 0.4 part of honey and 0.1 part of ginseng.
4. The preparation method of the microbial oral liquid is characterized by comprising the following steps of:
(1) Cleaning red date, black medlar, mulberry, sea buckthorn, black fleece-flower root and ginseng with clear water;
(2) Soaking fructus Jujubae, mori fructus, fructus Hippophae, radix Polygoni Multiflori, and Ginseng radix in mineral water, and decocting;
(3) Stopping heating, adding brown sugar, adding fructus Lycii when the temperature reaches 45-55 deg.C, adding Mel when the temperature is reduced to 17-23 deg.C, cooling, filtering to obtain filtrate, adding original bacteria, placing into fermentation tank, sealing, fermenting, and making into microorganism oral liquid.
5. The method according to claim 4, wherein the soaking time in the step (2) is 40min.
6. The preparation method according to claim 5, wherein the specific process of the decoction in the step (2) is as follows: decocting with strong fire until boiling, and decocting with slow fire for 30min.
7. The method according to claim 6, wherein the fermentation time in the step (3) is 15 days.
8. Use of the preparation method according to any one of claims 4 to 7 for the preparation of a microbial oral liquid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210898904.5A CN115153028A (en) | 2022-07-28 | 2022-07-28 | Microbial oral liquid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210898904.5A CN115153028A (en) | 2022-07-28 | 2022-07-28 | Microbial oral liquid |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115153028A true CN115153028A (en) | 2022-10-11 |
Family
ID=83477932
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210898904.5A Pending CN115153028A (en) | 2022-07-28 | 2022-07-28 | Microbial oral liquid |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115153028A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105011127A (en) * | 2014-04-23 | 2015-11-04 | 广西玉草中草药开发有限公司 | Golden camellia enzyme oral solution capable of enhancing immunity and preparation method thereof |
CN105011128A (en) * | 2014-04-23 | 2015-11-04 | 广西南宁市林章中草药研究开发有限公司 | Plant essence enzyme oral solution capable of lowering hyperlipidemia, hypertension and hyperglycemia and preparation method thereof |
CN109527547A (en) * | 2018-12-03 | 2019-03-29 | 山东省农业科学院生物技术研究中心 | A kind of preparation method of lactobacillus-fermented mulberries polyoses oral liquid |
-
2022
- 2022-07-28 CN CN202210898904.5A patent/CN115153028A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105011127A (en) * | 2014-04-23 | 2015-11-04 | 广西玉草中草药开发有限公司 | Golden camellia enzyme oral solution capable of enhancing immunity and preparation method thereof |
CN105011128A (en) * | 2014-04-23 | 2015-11-04 | 广西南宁市林章中草药研究开发有限公司 | Plant essence enzyme oral solution capable of lowering hyperlipidemia, hypertension and hyperglycemia and preparation method thereof |
CN109527547A (en) * | 2018-12-03 | 2019-03-29 | 山东省农业科学院生物技术研究中心 | A kind of preparation method of lactobacillus-fermented mulberries polyoses oral liquid |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105995976A (en) | Integrated enzyme powder having effects of reducing fat and losing weight and application thereof | |
CN105918821A (en) | Compound enzyme liquid having effects of lowering high blood lipids, high blood pressure and high blood sugar, and improving immunity, and preparation method thereof | |
CN110338402A (en) | A kind of compound probiotic powder and preparation method thereof | |
CN106798252B (en) | Natto product with effects of regulating intestines and stomach, reducing blood fat and dissolving thrombus | |
CN104382164A (en) | Beverage prepared from lucid ganoderma and black tea fungus | |
CN113017092B (en) | Fermentation type small molecule peptide mixed solution for regulating blood sugar and preparation method and application thereof | |
CN106360420A (en) | Preparation method of fermentation vinegar egg juice | |
CN111557404A (en) | Digestion-aiding probiotic solid beverage and preparation method thereof | |
CN111329055B (en) | Preparation method of trifoliate acanthopanax enzyme | |
CN109566933A (en) | A kind of fermentation compound drink and preparation method thereof | |
CN105768070A (en) | Functional nutritional food for regulating intestines and stomach | |
CN110862897A (en) | Mulberry leaf and silkworm chrysalis yellow wine and its making process | |
CN110692884A (en) | Probiotic health-care beverage assisting in reducing hypertension, hyperglycemia and hyperlipidemia | |
CN102813260B (en) | Multifunctional fruit and vegetable beverage and preparation method thereof | |
CN104351900A (en) | Biological type drink taking glutinous rice as raw material, and preparation of biological type drink | |
CN108402454B (en) | Red-core pitaya enzyme, preparation method and application thereof | |
CN110547447A (en) | Royal jelly collagen fruit enzyme and preparation method thereof | |
CN113455602A (en) | Plant enzyme peptide beverage and preparation method thereof | |
CN108244654A (en) | Caterpillar fungus nutritire breakfast flour | |
CN112167491A (en) | Preparation method of medicinal and edible fermented beverage with effect of relieving enteritis | |
CN110604295A (en) | Composite bone peptide and preparation method thereof | |
CN115153028A (en) | Microbial oral liquid | |
CN102488213B (en) | Bioorganic nutrient solution | |
CN109620903A (en) | A kind of health instant powder with improvement intestinal absorption ability | |
CN114617254A (en) | Grape seed, angelica dahurica and mulberry enzyme with functions of maintaining beauty, keeping young, moistening intestines and relaxing bowels |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |